Feds to Biotech: No More Fibbing!

Feds to Biotech: No More Fibbing!
“A little-noted change in drug-approval procedures is a step toward avoiding more ImClone-style stock scandals “


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!